The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
The DOI matches its Crossref record; 250 of the 251 references it cites were found in a registry or an index.
Abstract
Newer generation antidepressant drugs (ADs) are widely used as the first line of treatment for major depressive disorders and are considered to be safer than tricyclic agents. In this critical review, we evaluated the literature on adverse events, tolerability and safety of selective serotonin reuptake inhibitors, serotonin noradrenaline reuptake inhibitors, bupropion, mirtazapine, trazodone, agomelatine, vilazodone, levomilnacipran and vortioxetine. Several side effects are transient and may disappear after a few weeks following treatment initiation, but potentially serious adverse events may persist or ensue later. They encompass gastrointestinal symptoms (nausea, diarrhea, gastric bleeding, dyspepsia), hepatotoxicity, weight gain and metabolic abnormalities, cardiovascular disturbances (heart rate, QT interval prolongation, hypertension, orthostatic hypotension), genitourinary symptoms (urinary retention, incontinence), sexual dysfunction, hyponatremia, osteoporosis and risk of fractures, bleeding, central nervous system disturbances (lowering of seizure threshold, extrapyramidal side effects, cognitive disturbances), sweating, sleep disturbances, affective disturbances (apathy, switches, paradoxical effects), ophthalmic manifestations (glaucoma, cataract) and hyperprolactinemia. At times, such adverse events may persist after drug discontinuation, yielding iatrogenic comorbidity. Other areas of concern involve suicidality, safety in overdose, discontinuation syndromes, risks during pregnancy and breast feeding, as well as risk of malignancies. Thus, the rational selection of ADs should consider the potential benefits and risks, likelihood of responsiveness to the treatment option and vulnerability to adverse events. The findings of this review should alert the physician to carefully review the appropriateness of AD prescription on an individual basis and to consider alternative treatments if available.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Common side effects include nausea, vomiting, diarrhea, headache, insomnia, and agitation (104).”
From The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease (2023) · cites this paper as [104]
In the citing paper
“Another drawback of long-term antidepressant treatment is concerned with the serious and bothersome side effects that may ensue with SSRI and SNRI, such as high rates of sexual dysfunction, bleeding (in particular gastrointestinal), weight gain, risk of fracture and osteoporosis, and hyponatremia.73”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [73]
In the citing paper
“Examples are switching from unipolar to bipolar course with antidepressant drugs [6,31] and supersensitivity psychosis, the onset of psychotic symptoms and co-occurring movement disorder with antipsychotic medications [4].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
In the citing paper
“For instance, several side effects of antidepressants are transient and may disappear after a few weeks following treatment initiation, but potentially serious adverse events may persist or ensue later.”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
In the citing paper
“Since gastric symptomatology did not follow the somatic patterns typical of anxiety disturbances, venlafaxine was also suspected as a iatrogenic cause [6].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Barbui, C., Hotopf, M., Freemantle, N., Boynton, J., Churchill, R., Eccles, M., Geddes, Jr., Hardy, R., Lewis, G., & Mason, J. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002791 · Cited by 86
RetractedProjections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Suicide and suicidal behaviour
Turecki, G., & Brent, D. A. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00234-2 · Cited by 2,338
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Prevalence of Depression During Pregnancy: Systematic Review
Bennett, H. A., Einarson, A., Taddio, A., Koren, G., & Einarson, T. R. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000116689.75396.5f · Cited by 1,725
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Apathy and the Functional Anatomy of the Prefrontal Cortex–Basal Ganglia Circuits
Levy, R., & Dubois, B. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj043 · Cited by 1,285
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Kessler, R. C. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.11.005 · Cited by 871
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833
Research works printed but not linked: 2
- 10.1345/aph.1A254 · doi:10.1345/aph.1a254 · Paper page
- 10.1210/endo.133.2.8344205 · doi:10.1210/endo.133.2.8344205 · Paper page
Cited by
Items 101–200 of 654
Chiappini, S., & Schifano, F. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000814 · Cited by 44
Gheysens, T., Eede, F. V. D., & Picker, L. D. (2024) · European Psychiatry · doi:10.1192/j.eurpsy.2024.11 · Cited by 54
Jacobsen, P. L., Zhong, W., Nomikos, G. G., & Clayton, A. H. (2019) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2019.06.018 · Cited by 46
White, E. K., Groeneveld, K. M., Tittle, R. K., Bolhuis, N. A., Martin, R., Royer, T. G., & Fotuhi, M. (2017) · NeuroRegulation · doi:10.15540/nr.4.1.37 · Cited by 43
Adamo, D., Pecoraro, G., Coppola, N., Calabria, E., Aria, M., & Mignogna, M. D. (2020) · Oral Diseases · doi:10.1111/odi.13602 · Cited by 50
Clinically relevant drug interactions between statins and antidepressants
Palleria, C., Roberti, R., Iannone, L. F., Tallarico, M., Barbieri, M. A., Vero, A., Manti, A., Sarro, G. D., Spina, E., & Russo, E. (2019) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13058 · Cited by 43
Diagnosis and Management of Cyclic Vomiting Syndrome: A Critical Review
Frazier, R., Li, B. U. K., & Venkatesan, T. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002216 · Cited by 46
Weight gain during incarceration: systematic review and meta‐analysis
Gebremariam, M. K., Nianogo, R. A., & Arah, O. A. (2017) · Obesity Reviews · doi:10.1111/obr.12622 · Cited by 43
Vázquez-Bourgón, J., Pérez‐Iglesias, R., de la Foz, V. O., Pinilla, P. S., Díaz, Á., & Crespo‐Facorro, B. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4763-x · Cited by 43
Vortioxetina: una nueva alternativa en el trastorno depresivo mayor
Salagre, E., Grande, I., Solé, B., Sánchez‐Moreno, J., & Vieta, E. (2017) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2017.06.006 · Cited by 45
Self-citationLan, T., Wu, Y., Zhang, Y., Li, S., Zhu, Z., Wang, L., Mao, X., Li, Y., Fan, C., Wang, W., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02479-x · Cited by 46
Picañol, J., & Castellanos, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12227080 · Cited by 49
Cardiovascular Safety of Psychiatric Agents: A Cautionary Tale
Manolis, T. A., Manolis, A. S., & Manolis, A. S. (2018) · Angiology · doi:10.1177/0003319718780145 · Cited by 41
What is the evidence for mirtazapine in treating cancer-related symptomatology? A systematic review
Economos, G. P. S., Lovell, N., Johnston, A., & Higginson, I. J. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-05229-7 · Cited by 44
Grace, S. L., Medina-Inojosa, J. R., Thomas, R. J., Krause, H., Vickers-Douglas, K. S., Palmer, B. A., & Lopez-Jimenez, F. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000486794 · Cited by 39
Is There a Potential of Misuse for Venlafaxine and Bupropion?
Schifano, F., & Chiappini, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00239 · Cited by 38
Dold, M., Bartova, L., Rupprecht, R., & Kasper, S. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000477770 · Cited by 38
Mao, Q., Zhang, H., Zhang, Z., Lu, Y., Pan, J., Guo, D., Huang, L., Tian, H., & Ma, K. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155510 · Cited by 44
Heart–Brain Axis: A Narrative Review of the Interaction between Depression and Arrhythmia
Fang, S., & Zhang, W. Y. (2024) · Biomedicines · doi:10.3390/biomedicines12081719 · Cited by 45
What Is New about New Antidepressants?
Dubovsky, S. L. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000488945 · Cited by 37
Evaluation & Treatment of Psychological Effects of Stroke
Devereux, N., & Berns, A. M. (2023) · Delaware Journal of Public Health · doi:10.32481/djph.2023.08.011 · Cited by 54
Multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain
Zuena, A. R., Maftei, D., Alemà, G., Moro, F. D., Lattanzi, R., Casolini, P., & Nicoletti, F. (2018) · Molecular Pain · doi:10.1177/1744806918808987 · Cited by 40
Neuroinflammation and Natural Antidepressants: Balancing Fire with Flora
Figueiredo Godoy, A. C., Frota, F. F., Araújo, L. P., Valenti, V. E., Pereira, E. D. S. B. M., Detregiachi, C. R. P., Galhardi, C. M., Caracio, F. C., Haber, R. S. A., Fornari Laurindo, L., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13051129 · Cited by 32
Novel therapies for glaucoma: a patent review (2013-2019)
Guglielmi, P., Carradori, S., Campestre, C., & Poce, G. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2019.1653279 · Cited by 36
Shafie, M., Rad, A. H., Mohammad‐Alizadeh‐Charandabi, S., & Mirghafourvand, M. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.06.005 · Cited by 41
Effects of virtual reality-based intervention on depression in stroke patients: a meta-analysis
Liu, H., Cheng, Z., Wang, S., Jia, Y., & Li, C. (2023) · Scientific Reports · doi:10.1038/s41598-023-31477-z · Cited by 41
Cardiovascular toxicity induced by SSRIs: Analysis of spontaneous reports submitted to FAERS
Chen, Y., Fan, Q., Liu, Y., Shi, Y., & Luo, H. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115300 · Cited by 39
Diabetes: how to manage diabetic peripheral neuropathy
Gandhi, M., Fargo, E. L., Prasad‐Reddy, L., Mahoney, K. M., & Isaacs, D. M. (2022) · Drugs in Context · doi:10.7573/dic.2021-10-2 · Cited by 38
Yoon, S., Iqbal, H., Kim, S. M., & Jin, M. (2023) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2022.116 · Cited by 37
McIntyre, R. S., Florea, I., Pedersen, M. M., & Christensen, M. C. (2023) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.23m14780 · Cited by 37
Psychotropic Drug-Associated Pneumonia in Older Adults
Rajamaki, B., Hartikainen, S. A., & Tolppanen, A. (2020) · Drugs & Aging · doi:10.1007/s40266-020-00754-1 · Cited by 40
Chiappini, S., Vickers‐Smith, R., Guirguis, A., Corkery, J., Martinotti, G., & Schifano, F. (2022) · Pharmaceuticals · doi:10.3390/ph15050565 · Cited by 40
Na, K., Jung, H., Cho, S., & Cho, S. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.002 · Cited by 34
Antidepressant mechanisms of ketamine’s action: NF-κB in the spotlight
Sokołowska, P., Karbownik, M. S., Jóźwiak-Bębenista, M., Dobielska, M., Kowalczyk, E., & Wiktorowska‐Owczarek, A. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115918 · Cited by 42
Acupuncture may play a key role in anti-depression through various mechanisms in depression
Li, P., Zhao, J., Wei, X., Luo, L., Chu, Y., Zhang, T., Zhu, A., & Yan, J. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00990-2 · Cited by 37
Mixed States: Modelling and Management
Malhi, G. S., Fritz, K., Elangovan, P., & Irwin, L. (2019) · CNS Drugs · doi:10.1007/s40263-019-00609-3 · Cited by 33
Precision non-implantable neuromodulation therapies: a perspective for the depressed brain
Borrione, L., Bellini, H., Razza, L. B., Ganho-Ávila, A., Baeken, C., Brem, A., Busatto, G. F., Carvalho, A. F., Chekroud, A. M., Daskalakis, Z. J., et al. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2019-0741 · Cited by 38
Self-citationSushma, G., Vaidya, B., Sharma, S., Devabattula, G., Bishnoi, M., Kondepudi, K. K., & Sharma, S. S. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109480 · Cited by 34
Siwek, M., Woroń, J., Wrzosek, A., Gupało, J., & Chrobak, A. A. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1271776 · Cited by 37
Schneider, M., Pauwels, P., Toto, S., Bleich, S., Grohmann, R., Heinze, M., & Greiner, T. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.05.001 · Cited by 33
Liu, L., Lv, X., Zhou, S., Liu, Q., Wang, J., Tian, H., Zhang, K., Wei, J., Wang, C., Chen, Q., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.06.020 · Cited by 32
The Relationship Between 5-Hydroxytryptamine and Its Metabolite Changes With Post-stroke Depression
Gu, S., He, Z., Xu, Q., Dong, J., Xiao, T., Liang, F., Ma, X., Wang, F., & Huang, J. H. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.871754 · Cited by 32
Psychiatric Medication Use and Weight Outcomes One Year After Bariatric Surgery
Hawkins, M., Leung, S., Lee, A. H., Wnuk, S., Cassin, S. E., Hawa, R., & Sockalingam, S. (2019) · Psychosomatics · doi:10.1016/j.psym.2019.10.009 · Cited by 33
Graff, L. A., Geist, R., Kuenzig, M. E., Benchimol, E. I., Kaplan, G. G., Windsor, J. W., Bitton, A., Coward, S., Jones, J. L., Lee, K., et al. (2023) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwad012 · Cited by 30
“Common side effects include nausea, vomiting, diarrhea, headache, insomnia, and agitation (104).”
BackgroundBenzodiazepines in anxiety disorders: Reassessment of usefulness and safety
Rickels, K., & Moeller, H. J. (2019) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1500031 · Cited by 30
“In regard to tolerability, new ADs such as SSRIs and SNRIs certainly cause disturbing adverse events (AEs), such as nausea, dizziness and sexual dysfunction, to mention only a few.”
BackgroundInfluentialCosci, F., & Chouinard, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00007-x · Cited by 41
Antidepressants during and after Menopausal Transition: A Systematic Review and Meta-Analysis
Wu, C.-K., Tseng, P., Wu, M., Li, D., Chen, T., Kuo, F., Stubbs, B., Carvalho, A. F., Chen, Y., Lin, P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-64910-8 · Cited by 29
Self-citationRajha, H. E., Abdelaal, R., Charfi, K., Alemadi, A. O., Al-Sheraim, A. S., Al-Maadid, M. A., Louati, Y., Doi, S. A. R., & Khaled, S. M. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.10.114 · Cited by 30
Periodic leg movements during sleep associated with antidepressants: A meta-analysis
Ferri, R., Mogavero, M. P., Bruni, O., Picchietti, D. L., & DelRosso, L. M. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105126 · Cited by 33
Witkin, J. M., Wallace, T. L., & Martin, W. J. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_186 · Cited by 31
Wang, Z., Xu, G., Li, Z., Xiao, X., Tang, J., & Bai, Z. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s344071 · Cited by 32
Vortioxetine: A new alternative for the treatment of major depressive disorder
Salagre, E., Grande, I., Solé, B., Sánchez‐Moreno, J., & Vieta, E. (2018) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2018.02.005 · Cited by 31
Self-citationImpact of Antidepressants on Weight Gain: Underlying Mechanisms and Mitigation Strategies
Mouawad, M., Nabipur, L., & Agrawal, D. K. (2025) · Archives of Clinical and Biomedical Research · doi:10.26502/acbr.50170450 · Cited by 39
Use of Sertraline in Hemodialysis Patients
Kubanek, A., Paul, P., Przybylak, M., Kanclerz, K., Rojek, J. J., Renke, M., Bidzan, L., & Grabowski, J. (2021) · Medicina · doi:10.3390/medicina57090949 · Cited by 32
Tang, Y., Wang, H., Nie, K., Gao, Y., Su, H., Wang, Z., Lu, F., Huang, W., & Dong, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113284 · Cited by 29
Effects of Urban Forest Therapy Program on Depression Patients
Yeon, P., Kim, I.-O., Kang, S.-N., Lee, N.-E., Kim, G.-Y., Min, G.-M., Chung, C.-Y., Lee, J.-S., Kim, J.-G., & Shin, W.-S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010507 · Cited by 30
Psychopharmacology: From serendipitous discoveries to rationale design, but what next?
Robinson, E. S. J. (2018) · Brain and Neuroscience Advances · doi:10.1177/2398212818812629 · Cited by 28
Cosci, F., Mansueto, G., & Fava, G. A. (2020) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2020.1779308 · Cited by 29
Self-citationSertraline as a treatment option for temper outbursts in Prader–Willi syndrome
Deest, M., Jakob, M. M., Seifert, J., Bleich, S., Frieling, H., & Eberlein, C. K. (2020) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62041 · Cited by 27
Pharmacodynamic Drug–Drug interactions of QT-prolonging drugs in hospitalized psychiatric patients
Hefner, G., Hahn, M., Hiemke, C., Toto, S., Wolff, J., Roll, S. C., & Klimke, A. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-020-02291-y · Cited by 29
Hong, X., Chen, R., Zhang, L., Yan, L., Li, J., & Zha, J. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.155017 · Cited by 26
Sun, L., Liu, T., Liu, J., Gao, C., & Zhang, X. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.929781 · Cited by 31
Bidirectional Relations Between Anxiety, Depression, and Cancer: A Review
Montazersaheb, S., Soofiyani, S. R., Nakhlband, A., Farahzadi, R., Saeedi, N., & Barzegar, H. (2022) · Current Drug Targets · doi:10.2174/1389450123666220922094403 · Cited by 32
Su, W., Hu, T., & Jiang, C. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230809112028 · Cited by 29
Nunes, C. S. A., Maes, M. H. J., Roomruangwong, C., Moraes, J. B., Bonifácio, K. L., Vargas, H. O., Barbosa, D. S., Anderson, G., de Melo, L. G. P., Drozdstoj, S., et al. (2018) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12918 · Cited by 30
Self-citationPsychotherapy in recurrent depression: efficacy, pitfalls, and recommendations
Cosci, F., Guidi, J., Mansueto, G., & Fava, G. A. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1804870 · Cited by 31
Self-citationTransdermal Route: A Viable Option for Systemic Delivery of Antidepressants
Tijani, A. O., Nunez, E., Singh, K., Khanna, G., & Puri, A. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.05.015 · Cited by 29
Hammami, A. S., Jellazi, M., Mahjoub, L., Fedhila, M., & Hammami, S. O. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.754047 · Cited by 26
Fugger, G., Bartova, L., Fabbri, C., Fanelli, G., Dold, M., Swoboda, M. M. M., Kautzky, A., Zohar, J., Souery, D., Mendlewicz, J., et al. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01368-3 · Cited by 29
Chenchula, S., Shubham, A., Jhaj, R., Rozatkar, A. R., Modak, T., Jitendra, S., Shamim, M. A., & Balakrishnan, S. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.09.041 · Cited by 27
3D-ALMOND-QSAR Models to Predict the Antidepressant Effect of Some Natural Compounds
Avram, S., Stan, M. S., Udrea, A.-M., Buiu, C., Boboc, A. A., & Mernea, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091449 · Cited by 28
Mi, W., Yang, F., Li, H., Xu, X., Li, L., Tan, Q., Wang, G., Zhang, K., Tian, F., Luo, J., et al. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab074 · Cited by 29
Wang, P., Zhang, N., Ma, S., Kang, L., Wang, W., Zong, X., Bai, H., Li, R., & Liu, Z. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.791230 · Cited by 25
Deo, N., & Redpath, G. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.804592 · Cited by 36
Jóźwiak-Bębenista, M., Sokołowska, P., Siatkowska, M., Panek, C. A., Komorowski, P., Kowalczyk, E., & Wiktorowska‐Owczarek, A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040846 · Cited by 25
Wang, H., Liu, J., He, J., Huang, D., Xi, Y., Xiao, T., Ouyang, Q., Zhang, S., Wan, S., & Chen, X. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1063489 · Cited by 27
Montano, C. B., Jackson, W., Vanacore, D., & Weisler, R. H. (2023) · Postgraduate Medicine · doi:10.1080/00325481.2023.2189868 · Cited by 31
Sexual Dysfunction Induced by Antidepressants—A Pharmacovigilance Study Using Data from VigiBaseTM
Zeiss, R., Malejko, K., Connemann, B. J., Gahr, M., Durner, V., & Graf, H. (2024) · Pharmaceuticals · doi:10.3390/ph17070826 · Cited by 20
Goerigk, S. A., Padberg, F., Bühner, M., Sarubin, N., Kaster, T. S., Daskalakis, Z. J., Blumberger, D. M., Borrione, L., Razza, L. B., & Brunoni, A. R. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00935-x · Cited by 26
Self-citationAmrein, M. A., Hengartner, M. P., Näpflin, M., Farcher, R., & Huber, C. A. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03559-4 · Cited by 23
“Prolonged use of AD has received increasing criticism in recent years as it can increase the risk of adverse effects over time, for example, weight change, sleep disturbance, and persistent sexual dysfunction [7, 11, 18, 19].”
BackgroundFang, X. J., Wu, Y., Dai, Y., Xiao, H., Li, S., Chen, X., Yuan, M., Guo, Y., Ma, L., Lin, D., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c10733 · Cited by 27
Hong, X., Zhang, L., & Zha, J. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.119175 · Cited by 15
Ishtiak‐Ahmed, K., Köhler‐Forsberg, O., Mortensen, E. L., Nierenberg, A. A., & Gasse, C. (2023) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2023.03.009 · Cited by 28
Akbar, M., Wandy, A., Soraya, G. V., Goysal, Y., Lotisna, M., & Basri, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18184 · Cited by 29
Greenberg, J. M., Smith, K. P., Kim, T. Y., Naghdechi, L., & IsHak, W. W. (2017) · Springer eBooks · doi:10.1007/978-3-319-52539-6_34 · Cited by 27
How could N-Methyl-D-Aspartate Receptor Antagonists Lead to Excitation Instead of Inhibition?
Su, T., Lu, Y., Geng, Y., Lü, W., & Chen, Y. (2018) · Brain Science Advances · doi:10.26599/bsa.2018.2018.9050009 · Cited by 27
Moloney, D. J., O’Connor, J., Newman, L., Scarlett, S., Hernández, B., Kenny, R. A., & Romero‐Ortuño, R. (2020) · Age and Ageing · doi:10.1093/ageing/afaa174 · Cited by 27
Wu, X., Tu, M., Yu, Z., Cao, Z., Qu, S., Chen, N., Jin, J., Xiong, S., Yang, J., Pei, S., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-02036-5 · Cited by 28
Tondt, J., & Bays, H. E. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2022.100017 · Cited by 24
Hicks, A. J., Clay, F. J., James, A. C., Hopwood, M., & Ponsford, J. L. (2022) · Neuropsychology Review · doi:10.1007/s11065-022-09543-6 · Cited by 26
The risk of glaucoma and serotonergic antidepressants: A systematic review and meta-analysis
Wang, H., Tseng, P., Stubbs, B., Carvalho, A. F., Li, D., Chen, T., Lin, P., Hsueh, Y.-T., Chen, Y., Chen, Y., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.07.079 · Cited by 24
Self-citationNagashima, T., Hayakawa, T., Akimoto, H., Minagawa, K., Takahashi, Y., & Asai, S. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2573 · Cited by 24
Kearns, B., Cooper, K. L., Orr, M., Essat, M., Hamilton, J. A., & Cantrell, A. J. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s356414 · Cited by 22
Psilocybin’s Potential Mechanisms in the Treatment of Depression: A Systematic Review
Lee, H. J., Tsang, V. W. L., Chai, B. S., Lin, M. C., Howard, A. K., Uy, C. E., & Elefante, J. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2223195 · Cited by 22
Brišnik, V., Vukas, J., Jung‐Sievers, C., Lukaschek, K., Alexander, G. C., Thiem, U., Thürmann, P., Schüle, C., Fischer, S., Baum, E., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03397-w · Cited by 26
Meister, R., Lanio, J., Fangmeier, T., Härter, M. C., Schramm, E., Zobel, I., Hautzinger, M., Nestoriuc, Y., & Kriston, L. (2019) · Journal of Clinical Psychology · doi:10.1002/jclp.22869 · Cited by 23
Miuli, A., Pettorruso, M., Stefanelli, G., Giovannetti, G., Cavallotto, C., Susini, O., Pasino, A., Bubbico, G., Risio, L. D., Petta, G. D., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115251 · Cited by 21
Cosgrove, L., Shaughnessy, A. F., Peters, S. M., Lexchin, J., Bursztajn, H. J., & Bero, L. A. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000458727 · Cited by 20
Gao, C., Kong, S., Guo, B., Liang, X., Duan, H.-F., & Li, D. (2019) · Medical Science Monitor · doi:10.12659/msm.912922 · Cited by 20
Gutiérrez‐Abejón, E., Herrera‐Gómez, F., Criado-Espegel, P., & Alvarez, E. (2020) · Pharmaceuticals · doi:10.3390/ph13040061 · Cited by 20
Metadata
- Authors
- Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Universidade de São Paulo (BR)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- University at Buffalo, State University of New York (US)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 85
- Issue
- 5
- Pages
- 270-288
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2477696699
- Semantic Scholar
- 4af046d5cf1f48ed09514ffef416d2de5c0d29cf
- Cited by
- 650
- References
- 251
- Citations by year
- 2026: 46 · 2025: 67 · 2024: 95 · 2023: 84 · 2022: 81 · 2021: 75 · 2020: 55 · 2019: 54 · 2018: 50 · 2017: 38 · 2016: 4
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- newer antidepressants, antidepressant side effects, drug safety, tolerability, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, bupropion, mirtazapine, trazodone, agomelatine, vilazodone, levomilnacipran, vortioxetine, gastrointestinal adverse effects, hepatotoxicity, weight gain, QT prolongation, sexual dysfunction, hyponatremia, osteoporosis, paradoxical effects, suicidality, antidepressant overdose, discontinuation syndrome, pregnancy and lactation, cancer risk, drug selection
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Humans, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.